Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
1-A
1-A POS
1-A-W
1-A/A
1-K
1-K/A
1-SA
1-SA/A
1-U
1-U/A
1-Z
1-Z-W
1-Z/A
1/A
10-12B
10-12B/A
10-12G
10-12G/A
10-D
10-D/A
10-K
10-K/A
10-K405
10-K405/A
10-KT
10-KT/A
10-Q
10-Q/A
10-QSB
10-QSB/A
10-QT
10-QT/A
10KSB
11-K
11-K/A
11-KT
13F-HR
13F-HR/A
13F-NT
13F-NT/A
13FCONP
144
144/A
15-12B
15-12B/A
15-12G
15-12G/A
15-15D
15-15D/A
15F-12B
15F-12G
15F-12G/A
15F-15D
18-K
18-K/A
19B-4E
2-E
20-F
20-F/A
20FR12B
20FR12B/A
20FR12G/A
24F-2NT
24F-2NT/A
25
25-NSE
25-NSE/A
25/A
253G1
253G2
253G3
3
3/A
305B2
305B2/A
4
4/A
40-17F1
40-17F1/A
40-17F2
40-17F2/A
40-17G
40-17G/A
40-202A
40-202A/A
40-206A
40-24B2
40-33
40-6B
40-6B/A
40-6C
40-6C/A
40-8B25
40-8F-2/A
40-APP
40-APP/A
40-F
40-F/A
40-OIP
40-OIP/A
40FR12B
40FR12B/A
424B1
424B2
424B3
424B4
424B5
424B7
424B8
424H
424H/A
425
485APOS
485B24E
485BPOS
485BXT
486APOS
486BPOS
486BXT
487
497
497AD
497J
497K
5
5/A
6-K
6-K/A
8-A12B
8-A12B/A
8-A12G
8-A12G/A
8-K
8-K/A
8-K12B
8-K12B/A
8-K12G3
8-K12G3/A
8-K15D5
8-K15D5/A
8-M
9-M
ABS-15G
ABS-15G/A
ABS-EE
ABS-EE/A
ADV-E
ADV-H-C
ADV-H-T
ADV-NR
ANNLRPT
APP NTC
APP ORDR
APP WD
APP WD/A
ARS
ARS/A
ATS-N
ATS-N/CA
ATS-N/MA
ATS-N/UA
AW
AW WD
C
C-AR
C-AR-W
C-AR/A
C-TR
C-U
C-U-W
C-W
C/A
C/A-W
CB
CB/A
CERT
CERTARCA
CERTBATS
CERTCBO
CERTNAS
CERTNYS
CERTPAC
CFPORTAL
CFPORTAL/A
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEF13E3
DEF13E3/A
DEFA14A
DEFA14C
DEFC14A
DEFC14A
DEFC14C
DEFM14A
DEFM14C
DEFN14A
DEFR14A
DEFR14C
DEFS14A
DEFS14C
DEL AM
DFAN14A
DFRN14A
DOS/A
DSTRBRPT
DSTRBRPT/A
EFFECT
F-1
F-1/A
F-10
F-10/A
F-10EF
F-1MEF
F-3
F-3/A
F-3ASR
F-3D
F-4
F-4/A
F-6
F-6 POS
F-6/A
F-6EF
F-7
F-8 POS
F-80
F-N
F-X
F-X/A
FOCUSN
FOCUSN/A
FWP
G-405
G-FIN/A
IRANNOTICE
MA
MA-A
MA-I
MA-I/A
MA-W
MA/A
MSD
MSD/A
N-14
N-14 8C
N-14 8C/A
N-14/A
N-14MEF
N-18F1
N-1A
N-1A/A
N-2
N-2/A
N-23C-2
N-23C3A
N-23C3B
N-2MEF
N-30B-2
N-30D
N-30D/A
N-4
N-4/A
N-54A
N-54C
N-6
N-6/A
N-6F
N-8A
N-8A/A
N-8B-2/A
N-8F
N-8F NTC
N-8F ORDR
N-8F/A
N-CEN
N-CEN/A
N-CSR
N-CSR/A
N-CSRS
N-CSRS/A
N-MFP2
N-MFP2/A
N-PX
N-PX/A
N-Q
N-Q/A
NO ACT
NPORT-P
NPORT-P/A
NRSRO-CE
NRSRO-CE/A
NRSRO-UPD
NSAR-A
NSAR-A/A
NSAR-AT
NSAR-B
NSAR-B/A
NSAR-BT
NSAR-U
NSAR-U/A
NT 10-K
NT 10-K/A
NT 10-Q
NT 10-Q/A
NT 11-K
NT 20-F
NT 20-F/A
NT N-CEN
NT N-MFP2
NT NPORT-EX
NT-NCSR
NT-NCSR/A
NT-NSAR
NT-NSAR/A
NTFNCSR
NTN 10Q
POS 8C
POS AM
POS AMI
POS EX
POS462B
POSASR
PRE 14A
PRE 14C
PREC14A
PREC14C
PREM14A
PREM14C
PREN14A
PRER14A
PRER14C
PRRN14A
PX14A6G
QRTLYRPT
QUALIF
REG-NR
REGDEX
REGDEX/A
REVOKED
RW
RW WD
S-1
S-1/A
S-11
S-11/A
S-11MEF
S-1MEF
S-1MEF
S-3
S-3/A
S-3ASR
S-3D
S-3DPOS
S-3MEF
S-4
S-4 POS
S-4/A
S-4MEF
S-6
S-6/A
S-8
S-8 POS
S-B
S-B/A
SC 13D
SC 13D/A
SC 13E
SC 13E/A
SC 13E1
SC 13E1/A
SC 13E3
SC 13E3/A
SC 13E4
SC 13E4/A
SC 13G
SC 13G/A
SC 14D9
SC 14D9/A
SC 14F1
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SC14D9C
SD
SD/A
SDR/A
SE
SEC STAFF
SEC STAFF ACTION
SEC STAFF LETTER
SF-1/A
SF-3
SF-3/A
SUPPL
T-3
T-3/A
TA-1
TA-1/A
TA-2
TA-2/A
TA-W
UPLOAD
WDL-REQ
X-17A-5
X-17A-5/A
Tags
Quarterly results
Invitae Corp (NVTA)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/08/2023
8-K
Quarterly results
Docs:
"
Invitae Reports Second Quarter 2023 Financial Results – Reported revenue of $120.5 million, a 12% year-over-year decrease due to exited businesses and geographies; pro forma revenue up slightly year-over-year –
"
05/09/2023
8-K
Quarterly results
Docs:
"
Invitae Reports First Quarter 2023 Financial Results – Reported revenue of $117.4 million, a 5% year-over-year decrease due to exited businesses and geographies; pro forma year-over-year revenue growth was ~10% –
"
02/28/2023
8-K
Quarterly results
Docs:
"
– Entered into a ~$336 million transaction for the 2024 convertible notes, effectively addressing ~96% of the amount outstanding – – Repaid its 2024 senior secured term loan in full, improving its balance sheet –
"
11/08/2022
8-K
Quarterly results
08/09/2022
8-K
Quarterly results
Docs:
"
Invitae Reports $136.6 Million in Revenue in Second Quarter of 2022 — Continued to execute towards operational excellence with portfolio optimization, broad cost controls and cash management
"
05/03/2022
8-K
Quarterly results
02/24/2022
8-K
Quarterly results
11/08/2021
8-K
Quarterly results
Docs:
"
Invitae Reports $114.4 Million in Revenue Driven by 296,000 in Billable Volume in Third Quarter of 2021 — Q3 2021 revenue increases more than 66% on volume growth of 89% from Q3 2020
"
08/03/2021
8-K
Quarterly results
Docs:
"
Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021 — Increased quarterly revenue by 152% year-over-year — —Increases guidance of revenue between $475-$500 million in 2021
"
05/04/2021
8-K
Quarterly results
02/17/2021
8-K
Quarterly results
11/05/2020
8-K
Quarterly results
Docs:
"
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
"
08/04/2020
8-K
Quarterly results
05/05/2020
8-K
Quarterly results
02/19/2020
8-K
Quarterly results
11/06/2019
8-K
Quarterly results
Docs:
"
Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples -- Increased quarterly revenue by 51% and volume by 65% year-over-year -- -- Now in network with Cigna, all major payers with approximately 295 million covered lives -- -- Hosting conference call and webcast today at 4:30pm Eastern/1:30pm Pacific --
"
08/06/2019
8-K
Quarterly results
05/07/2019
8-K
Quarterly results
Docs:
"
Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year -- On track to deliver more than 500,000 test samples, and more than $220 million in revenue in 2019 -- -- Signed eight new biopharma partnerships in the quarter, expanding the breadth of the genome network -- -- Management hosting conference call and webcast today at 4:30pm Eastern/1:30pm Pacific --
"
02/19/2019
8-K
Quarterly results
11/07/2018
8-K
Quarterly results
Docs:
"
Note Purchase Agreement, by and among Invitae Corporation, the guarantors from time to time party thereto, INN SA LLC, as collateral agent, and the purchasers listed therein or otherwise party thereto from time to time
",
"
Securities Purchase Agreement, by and among Invitae Corporation and the investors party thereto
",
"
Invitae Reports 106% Annual Revenue Growth Driven by 95% Annual Growth in Volume in Third Quarter 2018
"
05/09/2018
8-K
Quarterly results
Docs:
"
Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018
"
02/12/2018
8-K
Quarterly results
Docs:
"
Invitae reports over 150% volume and over 170% revenue growth for 2017 -- Annual test volume exceeds high end of guidance --
"
11/07/2017
8-K/A
Quarterly results
Docs:
"
8-K/A
",
"
Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017
"
11/06/2017
8-K
Quarterly results
Docs:
"
Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017 -- Momentum in base business complemented by strategic expansion into family health genetics -- -- Hosting conference call today at 4:30 pm ET / 1:30 pm PT --
"
08/07/2017
8-K
Quarterly results
Docs:
"
Invitae Reports Second Quarter 2017 Results
"
05/08/2017
8-K
Form 8-K - Current report
02/13/2017
8-K
Form 8-K - Current report
11/07/2016
8-K
Quarterly results
Docs:
"
Invitae Announces Third Quarter 2016 Financial Results, Secures Contracts with Top Five Largest Payers, and Grows Volume More Than 200% Year-Over-Year
"
08/08/2016
8-K
Form 8-K - Current report
05/09/2016
8-K
Form 8-K - Current report
02/09/2016
8-K
Form 8-K - Current report
11/05/2015
8-K
Form 8-K - Current report
08/06/2015
8-K
Form 8-K - Current report
05/12/2015
8-K
Form 8-K - Current report
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy